Chairman of the Board and Chief Executive Officer

Vice President, Global Strategy and Pipeline, Allergan Aesthetics

Patent rejected for MNC’s cancer drug; generics likely to enter market

Firms advise on RemeGen’s USD5.6bn AbbVie licensing deal

After AbbVie and Genmab's ph. 3 survival miss for Epkinly in DLBCL, what's next?

Factbox-Global drugmakers rush to boost US presence as tariff threat looms

0.4000000059604645

Director, Medical Affairs-Facial Aesthetics Portfolio and Body Contouring

AbbVie is a company dedicated to discovering and delivering innovative medicines and solutions that address serious health issues. The Director, Medical Affairs will lead the strategic direction for the Facial Aesthetics and Body Contouring portfolio, collaborating with various teams to implement medical strategies and enhance stakeholder engagement.

Chief Medical Officer

Chief Operating and Financial Officer

Ex-Lazard Banker’s Insider Tips Reaped $41 Million Haul, US Says

6 people charged in $41M insider trading scheme tied to 2 biotechs

Kyverna Therapeutics, Immunome, Almonty Industries And Other Big Stocks Moving Higher On Monday

Olema Oncology rises 11.7%

Senior Director, Global Regulatory Strategy Lead - Regulatory Affairs

Olema Oncology is a cancer medicines company dedicated to impacting breast cancer and beyond. The Senior Director, Global Regulatory Strategy Lead - Regulatory Affairs will lead the development and execution of innovative regulatory strategies supporting Olema products and represent Regulatory Affairs on cross-functional teams, providing regulatory guidance and oversight.

Senior Director, Global Commercial Strategy – CF Pipeline Lead

Vertex Pharmaceuticals Inc operates at the forefront of scientific innovation, focusing on treatments for cystic fibrosis and other serious diseases. The Senior Director, Global Commercial Strategy CF Pipeline Lead is responsible for defining and overseeing the pipeline strategy and performance goals while leading cross-functional teams to support business objectives.

CEO, Skeletal Dysplasias (QED Therapeutics)

CEO and Founder

JPM26: Beam, Cabaletta, More Zero In on Regulatory Alignment After Tumultuous Year

Financings for Jan. 16, 2026

BridgeBio Announces Commercial Progress, Program Updates, and 2026 Milestones at the 44th Annual J.P. Morgan Healthcare Conference

BridgeBio to Participate in the J.P. Morgan Healthcare Conference

Associate Director, IT Medical Affairs Lead

BridgeBio is pioneering innovative approaches in biotech to develop life-changing medicines for patients with unmet needs. The Associate Director, IT Medical Affairs Lead, will shape and deliver the technology and data strategy for the global Medical Affairs teams, ensuring they have the necessary systems and insights for effective engagement and operational excellence.